- Home
- PHVS vs AGL Comparison
PHVS vs AGL Comparison
Compare PHVS & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- AGL
- Stock Information
- Founded
- PHVS 2015
- AGL 2016
- Country
- PHVS Switzerland
- AGL United States
- Employees
- PHVS N/A
- AGL N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- AGL Managed Health Care
- Sector
- PHVS Health Care
- AGL Health Care
- Exchange
- PHVS Nasdaq
- AGL Nasdaq
- Market Cap
- PHVS 909.5M
- AGL 968.6M
- IPO Year
- PHVS 2021
- AGL 2021
- Fundamental
- Price
- PHVS $16.49
- AGL $2.25
- Analyst Decision
- PHVS Strong Buy
- AGL Hold
- Analyst Count
- PHVS 5
- AGL 20
- Target Price
- PHVS $39.20
- AGL $4.47
- AVG Volume (30 Days)
- PHVS 59.6K
- AGL 5.1M
- Earning Date
- PHVS 05-13-2025
- AGL 05-06-2025
- Dividend Yield
- PHVS N/A
- AGL N/A
- EPS Growth
- PHVS N/A
- AGL N/A
- EPS
- PHVS N/A
- AGL N/A
- Revenue
- PHVS N/A
- AGL $5,988,958,000.00
- Revenue This Year
- PHVS N/A
- AGL N/A
- Revenue Next Year
- PHVS N/A
- AGL $9.89
- P/E Ratio
- PHVS N/A
- AGL N/A
- Revenue Growth
- PHVS N/A
- AGL 23.07
- 52 Week Low
- PHVS $11.51
- AGL $1.50
- 52 Week High
- PHVS $25.50
- AGL $7.73
- Technical
- Relative Strength Index (RSI)
- PHVS 51.83
- AGL 32.60
- Support Level
- PHVS $15.46
- AGL $2.17
- Resistance Level
- PHVS $16.99
- AGL $2.38
- Average True Range (ATR)
- PHVS 1.04
- AGL 0.17
- MACD
- PHVS -0.08
- AGL 0.01
- Stochastic Oscillator
- PHVS 71.48
- AGL 11.50
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.